Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...
Avoid common mistakes in multiplexing protein secretion assays. Discover best practices to ensure accurate results.
In order to improve care for people with multiple sclerosis (MS), we need to understand more about their disease. The way we measure the impact of MS on daily life has remained relatively unchanged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results